We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Vuitton handbag optional

10 December 2007 By Robert Cyran

Japan is the world s #2 drugs market. Yet its pharma groups are poor at R&D and face government pricing pressure. Eisai s $3.9bn takeover of MGI could just be the start of a pricy shopping spree for US biotech companies.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)